COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,843 Articles (22,553 medRxiv, 8,290 bioRxiv)

Most recent first Previous |  Page 286: Articles 2851-2860  | Next

A phase I/II clinical trial of intradermal, controllable self-replicating RNA vaccine EXG 5003 against SARS-CoV-2
Koseki, T., Teramachi, M., Koga, M., Ko, M. S. H., Amano, T., Yu, H., Amano, M., Leyder, E., Badiola, M., Ray, P., Kim, J., Ko, A. C., Achour, A., Weng, N.-p., Imai, T., Yoshida, H., Taniuchi, S., Shintani, A., Fujigaki, H., Kondo, M., Doi, Y.
10.1101/2023.10.07.23296699 — Posted: 2023-10-11
Snapshots from Cryo-ET of active SARS-CoV-2 virions
Fukuhara, H., Dokainish, H. M., Kita, S., Tabata, K., Takasu, A., Huiskonen, J. T., Anraku, Y., Senda, T., Stuart, D. I., Sasaki, M., Orba, Y., Suzuki, Y., Sawa, H., Maenaka, K.
10.1101/2023.10.10.561643 — Posted: 2023-10-11
Deep generative models predict SARS-CoV-2 Spike infectivity and foreshadow neutralizing antibody escape
Youssef, N. A., Ghantous, F., Gurev, S., Brock, K., Jaimes, J. A., Dauphin, A., Yurkovetskiy, L., Soto, D., Estaboulieh, R., Kotzen, B., Bosso, M., Lemieux, J., Luban, J. A., Seaman, M., Marks, D.
10.1101/2023.10.08.561389 — Posted: 2023-10-10
The impact of depression and childhood maltreatment experiences on psychological adaptation from lockdown to relaxation periods during the COVID-19 pandemic
Herpertz, J., Goltermann, J., Gruber, M., Blitz, R., Taylor, J., Brosch, K., Stein, F., Straube, B., Meinert, S., Kraus, A., Leehr, E. J., Repple, J., Redlich, R., Gutfleisch, L., Besteher, B., Ratzsch, J., Winter, A., Bonnekoh, L. M., Emden, D., Kircher, T., Nenadic, I., Dannlowski, U., Hahn, T., Opel, N.
10.1101/2023.10.10.23296796 — Posted: 2023-10-10
Surrogate virus neutralisation test based on nanoluciferase-tagged antigens to quantify inhibitory antibodies against SARS-CoV-2 and characterise Omicron-specific reactivity
Schoefbaenker, M., Neddermeyer, R., Guenther, T., Mueller, M. M., Romberg, M. L., Classen, N., Hennies, M. T., Hrincius, E. R., Ludwig, S., Kuehn, J. E., Lorentzen, E. U.
10.1101/2023.10.10.23296792 — Posted: 2023-10-10
Scaling COVID-19 rates with population size in the United States
Cruz, A. R., Enquist, B. J., Burger, J. R.
10.1101/2023.10.10.23296807 — Posted: 2023-10-10
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in Chicago
Kristensen, K., Boodram, B., Avila, W., Pineros, J., Latkin, C., Mackesy-Amiti, M.-E.
10.1101/2023.10.10.23296820 — Posted: 2023-10-10
SHIFTR enables the unbiased and multiplexed identification of proteins bound to specific RNA regions in live cells
Aydin, J., Gabel, A., Zielinski, S., Ganskih, S., Schmidt, N., Hartigan, C. R., Schenone, M., Carr, S. A., Munschauer, M.
10.1101/2023.10.09.561498 — Posted: 2023-10-10
SARS-CoV-2 antibodies cross-react and enhance dengue infection
Jakhar, K., Sonar, S., Singh, G., Sarkar, T., Tiwari, M., Kaur, J., Rathore, D. K., Lal, B., Kumar, S., Srivastav, P., Kumar, S., Phagna, V., Kumar, L., Gupta, V., Kshetrapal, P., Singh, S., Wadhwa, N., Thiruvengadam, R., Raghavan, S., Gosain, M., Shrivastava, T., Bhattacharyya, S., Bhattacharya, J., Asthana, S., Mani, S.
10.1101/2023.10.09.557914 — Posted: 2023-10-10
Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
Frei, L., Gao, B., Han, J., Taft, J. M., Irvine, E. B., Weber, C. R., Kumar, R., Eisinger, B., Reddy, S. T.
10.1101/2023.10.09.561492 — Posted: 2023-10-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).